BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22138706)

  • 1. Unexpected only pulmonary manifestation of sarcoidosis.
    Bodmann B; Havranek V; Kneussl M; Czernin J; Knoll P; Mirzaei S
    Nuklearmedizin; 2011; 50(6):N64-5. PubMed ID: 22138706
    [No Abstract]   [Full Text] [Related]  

  • 2. Sarcoidosis misdiagnosed as malignant tumors: a case report.
    Li Z; Li X; Song Z; Liu J; Dong M; Shi T; Ren D; Xu S; Chen J
    World J Surg Oncol; 2015 Dec; 13():333. PubMed ID: 26652015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET scan in management of pulmonary sarcoidosis.
    Tirpude S; Basu S; Joshi JM
    J Assoc Physicians India; 2013 Apr; 61(4):276. PubMed ID: 24482968
    [No Abstract]   [Full Text] [Related]  

  • 4. Multi-technique imaging of sarcoidosis.
    Balan A; Hoey ET; Sheerin F; Lakkaraju A; Chowdhury FU
    Clin Radiol; 2010 Sep; 65(9):750-60. PubMed ID: 20696303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoid-like reaction mimics progression of disease after induction chemotherapy for lung cancer.
    Chida M; Inoue T; Honma K; Murakami K
    Ann Thorac Surg; 2010 Dec; 90(6):2031-3. PubMed ID: 21095358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.
    Ludwig V; Fordice S; Lamar R; Martin WH; Delbeke D
    Clin Nucl Med; 2003 Mar; 28(3):176-9. PubMed ID: 12592122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental detection of concurrent extramedullary plasmacytoma and amyloidoma of the nasopharynx on [18F]fluorodeoxyglucose positron emission tomography/computed tomography.
    Yoshida A; Borkar S; Singh B; Ghossein RA; Schöder H
    J Clin Oncol; 2008 Dec; 26(35):5817-9. PubMed ID: 19001338
    [No Abstract]   [Full Text] [Related]  

  • 8. Variable problems in lymphomas: CASE 2. Sarcoidosis mimicking progressive lymphoma.
    Hollister D; Lee MS; Eisen RN; Fey C; Portlock CS
    J Clin Oncol; 2005 Nov; 23(31):8113-6. PubMed ID: 16258110
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudo-tumoural sarcoidosis.
    Thilmany S; Saelens C; Lhommel R; Lambert M
    Acta Clin Belg; 2013; 68(2):150-1. PubMed ID: 23967730
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
    Strobel K; Schaefer NG; Husarik DB; Hany TF; Steinert H
    Clin Nucl Med; 2006 Oct; 31(10):624-6. PubMed ID: 16985370
    [No Abstract]   [Full Text] [Related]  

  • 11. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
    Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis.
    Umeda Y; Demura Y; Morikawa M; Ameshima S; Tsuchida T; Fujibayashi Y; Okazawa H; Ishizaki T
    Respirology; 2011 May; 16(4):713-20. PubMed ID: 21382131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does 18F-fluorodeoxyglucose PET/CT have a role in the management of pulmonary and extra pulmonary sarcoidosis?
    Carbone R; Douroukas A; Arena V; Cantalupi D; Balleari E; Ghio R; Pelosi E
    Monaldi Arch Chest Dis; 2008 Jun; 69(2):81-2. PubMed ID: 18837423
    [No Abstract]   [Full Text] [Related]  

  • 14. FDG PET for gauging of sarcoid disease activity.
    Adams H; Keijsers RG; Korenromp IH; Grutters JC
    Semin Respir Crit Care Med; 2014 Jun; 35(3):352-61. PubMed ID: 25007087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of integrated FDG-PET/CT in sarcoidosis.
    Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
    Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenteric inclusion cyst: appearance at PET/CT.
    McMahon MA; Kerr J; O'Connell MJ
    Clin Nucl Med; 2008 Jun; 33(6):434-5. PubMed ID: 18496458
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidental finding of an endobronchial tumor by 18F-FDG PET/CT.
    Navales I; Garcia JR; Alvarez-Moro FJ; Navarro A; Escobar I; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):271-2. PubMed ID: 23046638
    [No Abstract]   [Full Text] [Related]  

  • 19. Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis.
    Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    Clin Nucl Med; 2007 Feb; 32(2):114-6. PubMed ID: 17242564
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiology-pathology conference: sclerosing hemangioma of the lung.
    Neuman J; Rosioreanu A; Schuss A; Turi G; Yung E; Trow TK; Williams L; Katz DS
    Clin Imaging; 2006; 30(6):409-12. PubMed ID: 17101410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.